AI in MedTech

KI/AI in MedTech

With the launch of ChatGPT on November 30, 2022, artificial intelligence (AI) experienced a huge boom worldwide. Within two months, 100 million people had registered for the chatbot developed by OpenAI. The already prominent topic developed into a megatrend in a short space of time. ChatGPT and competing products such as Google’s Gemini are generative […]

Read More… from AI in MedTech


MDR preparation – How to deal with the EUDAMED postponement?

MDR Preparation

Since the Medical Device Regulation (MDR) was published in 2017, we witnessed many changes and deadline postponements. It is also likely that there will be more in the future. For medical device manufacturers, the most significant change has been the extension of the transition periods. For the MDR and EUDAMED. Some medical device companies expressed […]

Read More… from MDR preparation – How to deal with the EUDAMED postponement?


Software as a Medical Device

Software as a Medical Device

Software as a Medical Device (SaMD) is a collective term for software used for medical purposes. SaMDs exist as stand-alone products and as parts of other medical devices. Their legal definition varies from country to country. For example, the Medical Device Regulation (MDR) defines them as follows: Software intended to be used alone or in […]

Read More… from Software as a Medical Device


Registration and Digital Marking of Medical Devices in Russia

Medical Devices in Russia

Anyone wishing to sell products in Russia, whether pharmaceuticals, spirits, or medical devices, must comply with certain regulations and, if necessary, guarantee the traceability of their products. A large-scale track-and-trace project in Russia has been transferring numerous product groups to a track-and-trace system for several years to reduce counterfeit products and illegal trade. According to […]

Read More… from Registration and Digital Marking of Medical Devices in Russia


EUDAMED transition period extended

EUDAMED transition period extension: final deadline in Q2 2029

In October 2023, the European Commission extended the transition period for EUDAMED’s introduction. The system was supposed to be fully functional in the second quarter of 2024. This and other deadlines have now been postponed by three years. The EU has not published an official explanation. However, it has been known for some time that […]

Read More… from EUDAMED transition period extended


Product Safety in Pharma & MedTech

product safety pharma

In the European Union, medicinal products and medical devices are only approved for the market if manufacturers can guarantee the safety of their products. If adverse events occur after the products have been placed on the market, the vigilance procedures of the respective industries take effect. This is because patient safety continues to be a […]

Read More… from Product Safety in Pharma & MedTech